Integrated genomic analyses of de novo pathways underlying atypical meningiomas
about
Genomic landscape of high-grade meningiomas.BAP1 mutations in high-grade meningioma: implications for patient care.Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas.An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures
P2860
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
@en
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
@nl
type
label
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
@en
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
@nl
prefLabel
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
@en
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
@nl
P2093
P2860
P50
P356
P1476
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
@en
P2093
Akdes Serin Harmancı
Alexander O Vortmeyer
Boris Krischek
Burçin Baran
E Zeynep Erson-Omay
Geneive Carrión-Grant
Jacob Baranoski
Jennifer Moliterno
Johannes Schramm
Kaya Bilgüvar
P2860
P2888
P356
10.1038/NCOMMS14433
P407
P577
2017-02-14T00:00:00Z